WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

🩺 Protocol Summary

This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diets (control arm) or to the walnut arm for 4-10 weeks depending on the window between their consent date and the date for RP.

Primary Research Facility: Cedars-Sinai Medical Center (Los Angeles, California)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Prostate Cancer?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged 18 Years or older? • (Protocol specifies male participants only)

🔍 Protocol Specified Minimum Age: 18 Years

Able to attend required clinic visits at Cedars-Sinai Medical Center (Los Angeles, California)?

🔍 Logistical Requirement: Site at Cedars-Sinai Medical Center

📍 Primary Site Map

Site: Cedars-Sinai Medical Center — Los Angeles, California

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.